190 related articles for article (PubMed ID: 9198176)
1. Antithrombin: molecular basis of deficiency.
Bayston TA; Lane DA
Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin and its inherited deficiency states.
van Boven HH; Lane DA
Semin Hematol; 1997 Jul; 34(3):188-204. PubMed ID: 9241705
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III: summary of first database update.
Lane DA; Olds RJ; Thein SL
Nucleic Acids Res; 1994 Sep; 22(17):3556-9. PubMed ID: 7937056
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
6. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
Kase F; Pospísil J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of antithrombin deficiency.
Luxembourg B; Delev D; Geisen C; Spannagl M; Krause M; Miesbach W; Heller C; Bergmann F; Schmeink U; Grossmann R; Lindhoff-Last E; Seifried E; Oldenburg J; Pavlova A
Thromb Haemost; 2011 Apr; 105(4):635-46. PubMed ID: 21264449
[TBL] [Abstract][Full Text] [Related]
8. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
Rodgers GM
Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
10. Complete antithrombin deficiency in mice results in embryonic lethality.
Ishiguro K; Kojima T; Kadomatsu K; Nakayama Y; Takagi A; Suzuki M; Takeda N; Ito M; Yamamoto K; Matsushita T; Kusugami K; Muramatsu T; Saito H
J Clin Invest; 2000 Oct; 106(7):873-8. PubMed ID: 11018075
[TBL] [Abstract][Full Text] [Related]
11. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
[No Abstract] [Full Text] [Related]
12. Molecular genetics of antithrombin deficiency.
Lane DA; Kunz G; Olds RJ; Thein SL
Blood Rev; 1996 Jun; 10(2):59-74. PubMed ID: 8813337
[TBL] [Abstract][Full Text] [Related]
13. [Molecular anomalies of coagulation inhibitors].
Aiach M
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):265-6. PubMed ID: 8337141
[No Abstract] [Full Text] [Related]
14. Antithrombin cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families.
Perry DJ; Daly ME; Tait RC; Walker ID; Brown K; Beauchamp NJ; Preston FE; Gyde H; Harper PL; Carrell RW
Thromb Haemost; 1998 Feb; 79(2):249-53. PubMed ID: 9493570
[TBL] [Abstract][Full Text] [Related]
15. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin Rybnik: a new point mutation (nt 683 G>T) associated with type I antithrombin deficiency in a patient with venous thromboembolism and recurrent superficial venous thrombosis.
Szymańska M; Alhenc-Gelas M; Undas A
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):579-80. PubMed ID: 23807486
[No Abstract] [Full Text] [Related]
17. [Advances in the molecular biological study of hereditary antithrombin III deficiency].
Chui H; Wang H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):162-4. PubMed ID: 11243148
[No Abstract] [Full Text] [Related]
18. A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop).
Olds RJ; Lane DA; Ireland H; Finazzi G; Barbui T; Abildgaard U; Girolami A; Thein SL
Thromb Res; 1991 Dec; 64(5):621-5. PubMed ID: 1808766
[No Abstract] [Full Text] [Related]
19. Familial antithrombin III deficiency.
Winter JH; Fenech A; Ridley W; Bennett B; Cumming AM; Mackie M; Douglas AS
Q J Med; 1982; 51(204):373-95. PubMed ID: 7156320
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
Sakuragawa N; Niiya K; Takahashi K; Hayashi T; Oguma Y; Saitoh S
Rinsho Byori; 1993 May; 41(5):492-505. PubMed ID: 8350512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
